Search Results - "psoriasis"

Spotlight on itolizumab in the treatment of psoriasis – current perspectives from India by Budamakuntla L, Shree-Lakshmi HV, Bansal A, Venkatarayaraju SK

Connect to this object online.

Use of Biological Therapies for the Management of Pustular Psoriasis: A New Era? by Megna M, Camela E, Ruggiero A, Battista T, Martora F, Cacciapuoti S, Potestio L

Connect to this object online.

Systemic Inflammation and Evidence of a Cardio-splenic Axis in Patients with Psoriasis by Kasper F. Hjuler, Lars C. Gormsen, Mikkel H. Vendelbo, Alexander Egeberg, Jakob Nielsen, Lars Iversen

Connect to this object online.

Evaluating guselkumab: an anti-IL-23 antibody for the treatment of plaque psoriasis by Yang EJ, Smith MP, Ly K, Bhutani T

Connect to this object online.

Psoriasis rupioides with marked nail abnormalities in a HIV-positive patient by Iwona Chlebicka, Adam Reich, Jacek Szepietowski

Connect to this object online.

Association of the attachment styles with depression, anxiety, and quality of life in patients with psoriasis by Onur Okan Demirci, Bilge Ates, Eser Sagaltici, Zehra Gizem Ocak, Ilknur Kivanc Altunay

Connect to this object online.

Widespread superficial dermatophytosis in patient on secukinumab for treatment of chronic plaque psoriasis by Shekhar Neema, Sehdev Singh, Niloy Pathak, M A Khan

Connect to this object online.

Eosinophil-Count-Derived Inflammatory Markers and Psoriasis Severity: Exploring the Link by Oana Mirela Tiucă, Silviu Horia Morariu, Claudia Raluca Mariean, Robert Aurelian Tiucă, Alin Codrut Nicolescu, Ovidiu Simion Cotoi

Connect to this object online.

New-Onset Blepharitis in a Patient Treated With Secukinumab for Severe Psoriasis by Maria Francesca Baracca, Filippo Viviani, Alessandro Pileri, Giacomo Clarizio, Federico Bardazzi

Connect to this object online.

Pulsed dye laser for nail psoriasis: not the first time and apparently not that efficacious! by Sidharth Sonthalia, Rahul Arora, Rashmi Sarkar

Connect to this object online.

Loss of expression of claudin-1 in psoriasis is associated with proliferative state of keratinocytes by Manoj Gopal Madakshira, Bishan Dass Radotra, Uma Nahar Saikia

Connect to this object online.

Anti-programmed cell death-1-induced plaque and guttate psoriasis by Toshiyuki Yamamoto

Connect to this object online.

The Relationship between Disease, Work and Sickness Absence among Psoriasis Patients by Parvin MANSOURI, Fateme VALIRAD, Mirsaeed ATTARCHI, Saber MOHAMMADI, Shiva HATAMI, Seyed Farzin MIRCHERAGHI, Mohammadreza RAHBAR, Reza CHALANGARI

Connect to this object online.

Dimethyl Fumarate as Therapeutic Alternative in Moderate-to-Severe Psoriasis: Our Experience by Rosés Gibert P, de la Torre Gomar FJ, Saenz Aguirre A, Gimeno Castillo J, González Pérez R

Connect to this object online.

COVID-19 in patients with psoriasis: A Latin American case series by Isabela Campo-Slebi, MD, María Fernanda Meza-Corso, MD, Paola Cárdenas, MD, Juan Raúl Castro-Ayarza, MD, Cesar González, MD, Carolina Cortés, MD, Manuel Franco, MD, Fernando Valenzuela, MD

Connect to this object online.

Infantile generalized pustular psoriasis: a case report and review of the literature by Yung-Shun Su, Gwo-Shing Chen, Cheng-Che E. Lan

Connect to this object online.

Co-occurrence of psoriasis, vitiligo, and lichen planus in a single patient by Swathi Neelagiri, B Janardhan, K Siva Rami Reddy, V Sreedhar

Connect to this object online.

mTORC1 and mTORC2 Levels in Patients With Psoriasis by İlayda Esna Gülsunay, İlknur Altunay, Tuğba Kum, Asli Aksu Cerman

Connect to this object online.

Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA by Timothy Fitzgerald, Maryia Zhdanava, Dominic Pilon, Aditi Shah, Annalise Hilts, Patrick Lefebvre, Steven R. Feldman

Connect to this object online.

Brodalumab for the treatment of moderate-to-severe psoriasis: case series and literature review by Pinter A, Bonnekoh B, Hadshiew IM, Zimmer S

Connect to this object online.